Cargando…
Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations
CONTEXT: The pathogenic effect of mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene (AIPmuts) in pituitary adenomas is incompletely understood. We have identified the primary mechanism of loss of function for missense AIPmuts. OBJECTIVE: This study sought to analyze the mecha...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971335/ https://www.ncbi.nlm.nih.gov/pubmed/27253664 http://dx.doi.org/10.1210/jc.2016-1307 |
_version_ | 1782446092844007424 |
---|---|
author | Hernández-Ramírez, Laura C. Martucci, Federico Morgan, Rhodri M. L. Trivellin, Giampaolo Tilley, Daniel Ramos-Guajardo, Nancy Iacovazzo, Donato D'Acquisto, Fulvio Prodromou, Chrisostomos Korbonits, Márta |
author_facet | Hernández-Ramírez, Laura C. Martucci, Federico Morgan, Rhodri M. L. Trivellin, Giampaolo Tilley, Daniel Ramos-Guajardo, Nancy Iacovazzo, Donato D'Acquisto, Fulvio Prodromou, Chrisostomos Korbonits, Márta |
author_sort | Hernández-Ramírez, Laura C. |
collection | PubMed |
description | CONTEXT: The pathogenic effect of mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene (AIPmuts) in pituitary adenomas is incompletely understood. We have identified the primary mechanism of loss of function for missense AIPmuts. OBJECTIVE: This study sought to analyze the mechanism/speed of protein turnover of wild-type and missense AIP variants, correlating protein half-life with clinical parameters. DESIGN AND SETTING: Half-life and protein–protein interaction experiments and cross-sectional analysis of AIPmut positive patients' data were performed in a clinical academic research institution. PATIENTS: Data were obtained from our cohort of pituitary adenoma patients and literature-reported cases. INTERVENTIONS: Protein turnover of endogenous AIP in two cell lines and fifteen AIP variants overexpressed in HEK293 cells was analyzed via cycloheximide chase and proteasome inhibition. Glutathione-S-transferase pull-down and quantitative mass spectrometry identified proteins involved in AIP degradation; results were confirmed by coimmunoprecipitation and gene knockdown. Relevant clinical data was collected. MAIN OUTCOME MEASURES: Half-life of wild-type and mutant AIP proteins and its correlation with clinical parameters. RESULTS: Endogenous AIP half-life was similar in HEK293 and lymphoblastoid cells (43.5 and 32.7 h). AIP variants were divided into stable proteins (median, 77.7 h; interquartile range [IQR], 60.7–92.9 h), and those with short (median, 27 h; IQR, 21.6–28.7 h) or very short (median, 7.7 h; IQR, 5.6–10.5 h) half-life; proteasomal inhibition rescued the rapid degradation of mutant proteins. The experimental half-life significantly correlated with age at diagnosis of acromegaly/gigantism (r = 0.411; P = .002). The FBXO3-containing SKP1–CUL1–F-box protein complex was identified as the E3 ubiquitin-ligase recognizing AIP. CONCLUSIONS: AIP is a stable protein, driven to ubiquitination by the SKP1–CUL1–F-box protein complex. Enhanced proteasomal degradation is a novel pathogenic mechanism for AIPmuts, with direct implications for the phenotype. |
format | Online Article Text |
id | pubmed-4971335 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Endocrine Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-49713352016-08-17 Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations Hernández-Ramírez, Laura C. Martucci, Federico Morgan, Rhodri M. L. Trivellin, Giampaolo Tilley, Daniel Ramos-Guajardo, Nancy Iacovazzo, Donato D'Acquisto, Fulvio Prodromou, Chrisostomos Korbonits, Márta J Clin Endocrinol Metab Original Articles CONTEXT: The pathogenic effect of mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene (AIPmuts) in pituitary adenomas is incompletely understood. We have identified the primary mechanism of loss of function for missense AIPmuts. OBJECTIVE: This study sought to analyze the mechanism/speed of protein turnover of wild-type and missense AIP variants, correlating protein half-life with clinical parameters. DESIGN AND SETTING: Half-life and protein–protein interaction experiments and cross-sectional analysis of AIPmut positive patients' data were performed in a clinical academic research institution. PATIENTS: Data were obtained from our cohort of pituitary adenoma patients and literature-reported cases. INTERVENTIONS: Protein turnover of endogenous AIP in two cell lines and fifteen AIP variants overexpressed in HEK293 cells was analyzed via cycloheximide chase and proteasome inhibition. Glutathione-S-transferase pull-down and quantitative mass spectrometry identified proteins involved in AIP degradation; results were confirmed by coimmunoprecipitation and gene knockdown. Relevant clinical data was collected. MAIN OUTCOME MEASURES: Half-life of wild-type and mutant AIP proteins and its correlation with clinical parameters. RESULTS: Endogenous AIP half-life was similar in HEK293 and lymphoblastoid cells (43.5 and 32.7 h). AIP variants were divided into stable proteins (median, 77.7 h; interquartile range [IQR], 60.7–92.9 h), and those with short (median, 27 h; IQR, 21.6–28.7 h) or very short (median, 7.7 h; IQR, 5.6–10.5 h) half-life; proteasomal inhibition rescued the rapid degradation of mutant proteins. The experimental half-life significantly correlated with age at diagnosis of acromegaly/gigantism (r = 0.411; P = .002). The FBXO3-containing SKP1–CUL1–F-box protein complex was identified as the E3 ubiquitin-ligase recognizing AIP. CONCLUSIONS: AIP is a stable protein, driven to ubiquitination by the SKP1–CUL1–F-box protein complex. Enhanced proteasomal degradation is a novel pathogenic mechanism for AIPmuts, with direct implications for the phenotype. Endocrine Society 2016-08 2016-06-02 /pmc/articles/PMC4971335/ /pubmed/27253664 http://dx.doi.org/10.1210/jc.2016-1307 Text en https://creativecommons.org/licenses/by/4.0/ This article has been published under the terms of the Creative Commons Attribution License (CC-BY; https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Copyright for this article is retained by the author(s). |
spellingShingle | Original Articles Hernández-Ramírez, Laura C. Martucci, Federico Morgan, Rhodri M. L. Trivellin, Giampaolo Tilley, Daniel Ramos-Guajardo, Nancy Iacovazzo, Donato D'Acquisto, Fulvio Prodromou, Chrisostomos Korbonits, Márta Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations |
title | Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations |
title_full | Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations |
title_fullStr | Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations |
title_full_unstemmed | Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations |
title_short | Rapid Proteasomal Degradation of Mutant Proteins Is the Primary Mechanism Leading to Tumorigenesis in Patients With Missense AIP Mutations |
title_sort | rapid proteasomal degradation of mutant proteins is the primary mechanism leading to tumorigenesis in patients with missense aip mutations |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971335/ https://www.ncbi.nlm.nih.gov/pubmed/27253664 http://dx.doi.org/10.1210/jc.2016-1307 |
work_keys_str_mv | AT hernandezramirezlaurac rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT martuccifederico rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT morganrhodriml rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT trivellingiampaolo rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT tilleydaniel rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT ramosguajardonancy rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT iacovazzodonato rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT dacquistofulvio rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT prodromouchrisostomos rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations AT korbonitsmarta rapidproteasomaldegradationofmutantproteinsistheprimarymechanismleadingtotumorigenesisinpatientswithmissenseaipmutations |